| Source: |
| Type: type of cell death |
| Situation in which a cell actively pursues a course toward death upon receiving certain stimuli. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die. |
| 8482- | MFrot, | Polyhedral magnetic nanoparticles induce apoptosis in gastric cancer stem cells and suppressing tumor growth through magnetic force generation |
| - | vitro+vivo, | GC, | NA |
| 2259- | MFrot, | MF, | Method and apparatus for oncomagnetic treatment |
| - | in-vitro, | GBM, | NA |
| 3493- | MFrot, | MF, | Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes |
| - | in-vivo, | GBM, | NA |
| - | Human, | Lung, | NA |
| 189- | MFrot, | MF, | Cancer treatment by magneto-mechanical effect of particles, a review |
| - | Review, | Var, | NA |
| 227- | MFrot, | MF, | Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway |
| - | in-vivo, | Lung, | A549 | - | in-vitro, | Lung, | A549 |
| 220- | MFrot, | MF, | Effect of low frequency magnetic fields on melanoma: tumor inhibition and immune modulation |
| - | in-vitro, | Melanoma, | B16-F10 |
| 203- | MFrot, | MF, | Rotating Magnetic Field Induced Oscillation of Magnetic Particles for in vivo Mechanical Destruction of Malignant Glioma |
| - | vitro+vivo, | GBM, | U87MG |
| 516- | MFrot, | immuno, | MF, | Anti-tumor effect of innovative tumor treatment device OM-100 through enhancing anti-PD-1 immunotherapy in glioblastoma growth |
| - | vitro+vivo, | GBM, | U87MG |
| 7382- | MFrot, | Inhibition of mitochondrial NADH:ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells |
| - | vitro+vivo, | GBM, | NA |
| 8460- | Mg, | Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy |
| - | vitro+vivo, | Var, | NA |
| 775- | Mg, | The Supplement of Magnesium Element to Inhibit Colorectal Tumor Cells |
| - | vitro+vivo, | CRC, | DLD1 |
| 777- | Mg, | Biodegradable Mg Implants Suppress the Growth of Ovarian Tumor |
| - | vitro+vivo, | Ovarian, | SKOV3 |
| 780- | Mg, | Degradable magnesium implants inhibit gallbladder cancer |
| - | vitro+vivo, | Gall, | NA |
| 9155- | MG, MIC-1, | The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo |
| - | in-vivo, | Mye, | NA |
| 9073- | MGF, | Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase |
| - | in-vitro, | MM, | NA |
| 9075- | MGF, | Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| - | in-vivo, | AD, | NA |
| 9080- | MGF, | Mangiferin targets PFKFB3 to inhibit glioblastoma progression by suppressing glycolysis and PI3K/AKT/mTOR signaling |
| - | vitro+vivo, | GBM, | NA |
| 9084- | MGF, | Mangiferin blocks proliferation and induces apoptosis of breast cancer cells via suppression of the mevalonate pathway and by proteasome inhibition |
| - | in-vitro, | BC, | NA |
| 9087- | MGF, | Mangiferin in human disease: Multifaceted mechanisms and applications (Review) |
| - | Review, | Var, | NA |
| 9089- | MGF, | Mangiferin targeting HSP90α induces DNA damage in cutaneous squamous cell carcinoma via the ROS/MAPK signaling pathway |
| - | in-vitro, | SCC, | NA |
| 8737- | MGO, | Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | 4T1 |
| 1891- | MGO, | Methylglyoxal induces mitochondria-dependent apoptosis in sarcoma |
| - | in-vitro, | SCC, | NA |
| 1890- | MGO, | The Dual-Role of Methylglyoxal in Tumor Progression – Novel Therapeutic Approaches |
| - | Review, | Var, | NA |
| 1782- | MLT, | Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities |
| - | Review, | Var, | NA |
| 8669- | MLT, | Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities |
| - | Review, | Lung, | NA |
| 8659- | MLT, | Cisplatin, | Melatonin Sensitizes OVCAR-3 Cells to Cisplatin through Suppression of PI3K/Akt Pathway |
| - | in-vitro, | Ovarian, | OVCAR-3 |
| 8660- | MLT, | Unraveling the impact of melatonin treatment: Oxidative stress, metabolic responses, and morphological changes in HuH7.5 hepatocellular carcinoma cells |
| - | in-vitro, | CCA, | HuH28 |
| 8671- | MLT, | Targeting mitochondrial metabolism in renal cell carcinoma with melatonin: Preclinical evidence and clinical perspectives |
| - | Review, | RCC, | NA |
| 8684- | MLT, | Intratumoral injection of melatonin enhances tumor regression in cell line-derived and patient-derived xenografts of head and neck cancer by increasing mitochondrial oxidative stress |
| - | in-vivo, | SCC, | CAL27 | - | in-vivo, | Tong, | SCC9 |
| 8693- | MLT, | Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin-induced apoptosis in neural cancer cells |
| - | in-vitro, | GBM, | U118MG | - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 8692- | MLT, | Melatonin as a Radio-Sensitizer in Cancer |
| - | Review, | Var, | NA |
| 8689- | MLT, | Role of melatonin in Alzheimer's disease: From preclinical studies to novel melatonin-based therapies |
| - | Review, | AD, | NA |
| 8687- | MLT, | Melatonin induces cell cycle arrest and suppresses tumor invasion in urinary bladder urothelial carcinoma |
| - | in-vitro, | CRC, | T24/HTB-9 | - | in-vitro, | Bladder, | UMUC3 |
| 8686- | MLT, | CAP, | Non-thermal plasma-treated melatonin inhibits the biological activity of HCC cells by increasing intracellular ROS levels and reducing RRM2 expression |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Liver, | HUH7 |
| 8685- | MLT, | Melatonin acts synergistically with pazopanib against renal cell carcinoma cells through p38 mitogen-activated protein kinase-mediated mitochondrial and autophagic apoptosis |
| - | vitro+vivo, | RCC, | 786-O |
| 8673- | MLT, | Therapeutic Potential of Melatonin in Gastrointestinal Cancers: Molecular Mechanisms, Preclinical Evidence and Clinical Implications |
| - | Review, | GC, | NA |
| 8683- | MLT, | Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment |
| - | in-vivo, | BC, | NA |
| 1063- | MLT, | HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | PC9 |
| 656- | MNPs, | MF, | Effects of combined delivery of extremely low frequency electromagnetic field and magnetic Fe3O4 nanoparticles on hepatic cell lines |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | Nor, | HL7702 |
| 1762- | MNPs, | Fe, | Triggering the apoptosis of targeted human renal cancer cells by the vibration of anisotropic magnetic particles attached to the cell membrane |
| - | in-vitro, | RCC, | NA |
| 8610- | MO, | Melissa officinalis extract induces apoptosis and inhibits proliferation in colon cancer cells through formation of reactive oxygen species |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | Colon, | T84 |
| 8909- | MO, | Effect of Moringa oleifera on inflammatory diseases: an umbrella review of 26 systematic reviews |
| - | Review, | Nor, | NA |
| 8910- | MO, | Moringa oleifera L. leaf extract induces cell cycle arrest and mitochondrial apoptosis in Dalton's Lymphoma: An in vitro and in vivo study |
| - | vitro+vivo, | lymphoma, | NA |
| 8911- | MO, | Anticancer Potential of Moringa Oleifera in Lung Cancer: A Mini Review of In vitro and In vivo Evidence |
| - | Review, | Lung, | NA |
| 8912- | MO, | Anticancer effect of Moringa oleifera in oral squamous cell carcinoma: a systematic review |
| - | Review, | Oral, | NA |
| 8917- | MO, | Harnessing Moringa oleifera for Immune Modulation in Cancer: Molecular Mechanisms and Therapeutic Potential |
| - | Review, | Var, | NA |
| 8895- | MOR, | Cisplatin, | Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin |
| - | in-vitro, | Ovarian, | TOV-21G | - | in-vitro, | Ovarian, | SKOV3 |
| 8898- | MOR, | Molecular mechanism of anti-cancerous potential of Morin extracted from mulberry in Hela cells |
| - | in-vitro, | Cerv, | HeLa |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:14 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid